RecruitingNCT06377462

Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection

Studying VEXAS syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Technische Universität Dresden
Principal Investigator: Katja Sockel, Dr. med.
TU Dresden
Enrollment: 500 target
Eligibility: 18 years · All sexes
Timeline: 2024 – 2030

Study locations (13)

Universitätsklinikum Aachen, Aachen, Germany
Klinikum Chemnitz gGmbH, Chemnitz, Germany
Universitätsklinikum Carl Gustav Carus, Dresden, Germany
Universitätsklinikum Düsseldorf, Düsseldorf, Germany
Evang. Kliniken Essen-Mitte, Essen, Germany
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
Universitätsklinikum Leipzig AöR, Leipzig, Germany
Universitätsmedizin Mannheim, Mannheim, Germany
Klinikum rechts der Isar TUM, München, Germany
Klinikum Osnabrück GmbH, Osnabrück, Germany
Helios Kliniken Schwerin GmbH, Schwerin, Germany
Robert Bosch Gesellschaft für Medizinische Forschung mb, Stuttgart, Germany
Krankenhaus der Barmherzigen Brüder, Trier, Germany

Collaborators

Bristol-Myers Squibb · University Hospital Munich

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06377462 on ClinicalTrials.gov

Other trials for VEXAS syndrome

Additional recruiting or active studies for the same condition.

See all trials for VEXAS syndrome →

← Back to all trials